Abstract Cancer sequencing projects are now measuring somatic muta-tions in large numbers of cancer genomes. A key challenge in interpreting these data is to distinguish driver mutations, mutations important for cancer development, from passenger mutations that have accumulated in somatic cells but without functional consequences. A common ap-proach to identify genes harboring driver mutations is a single gene test that identifies individual genes that are mutated in a significant number of cancer genomes. However, the power of this test is reduced by the mutational heterogeneity in most cancer genomes and by the necessity of estimating the background mutation rate (BMR). We investigate the problem of discovering driver pathways, groups of ...
AbstractThe availability of the human genome sequence and progress in sequencing and bioinformatic t...
Driver mutations are the genetic variants responsible for oncogenesis, but how specific somatic muta...
Understanding genetic events that lead to cancer initiation and progression remains one of the bigge...
Abstract Background Cancer sequencing projects are now measuring somatic mutations in large numbers ...
genome-wide measurements of somatic mutations in large numbers of cancer patients. A major challenge...
Technological advances in next-generation sequencing have uncovered a wide spectrum of aberrations i...
Background: Large-scale cancer genomic projects are providing lots of data on genomic, epigenomic an...
Identifying driver mutations in cancer is notoriously difficult. To date, recurrence of a mutation i...
Identifying driver mutations in cancer is notoriously difficult. To date, recurrence of a mutation i...
Abstract Background Recent advances in next-generation sequencing technologies have helped investiga...
Cancer drivers are genomic alterations that provide cells containing them with a selective advantage...
<div><p>Cancer drivers are genomic alterations that provide cells containing them with a selective a...
<div><p>Distinguishing the somatic mutations responsible for cancer (<i>driver</i> mutations) from r...
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc. Cancer genomes conta...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
AbstractThe availability of the human genome sequence and progress in sequencing and bioinformatic t...
Driver mutations are the genetic variants responsible for oncogenesis, but how specific somatic muta...
Understanding genetic events that lead to cancer initiation and progression remains one of the bigge...
Abstract Background Cancer sequencing projects are now measuring somatic mutations in large numbers ...
genome-wide measurements of somatic mutations in large numbers of cancer patients. A major challenge...
Technological advances in next-generation sequencing have uncovered a wide spectrum of aberrations i...
Background: Large-scale cancer genomic projects are providing lots of data on genomic, epigenomic an...
Identifying driver mutations in cancer is notoriously difficult. To date, recurrence of a mutation i...
Identifying driver mutations in cancer is notoriously difficult. To date, recurrence of a mutation i...
Abstract Background Recent advances in next-generation sequencing technologies have helped investiga...
Cancer drivers are genomic alterations that provide cells containing them with a selective advantage...
<div><p>Cancer drivers are genomic alterations that provide cells containing them with a selective a...
<div><p>Distinguishing the somatic mutations responsible for cancer (<i>driver</i> mutations) from r...
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc. Cancer genomes conta...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
AbstractThe availability of the human genome sequence and progress in sequencing and bioinformatic t...
Driver mutations are the genetic variants responsible for oncogenesis, but how specific somatic muta...
Understanding genetic events that lead to cancer initiation and progression remains one of the bigge...